Stories

Tech Logic

Tracks the technical systems, bottlenecks, and standards that reshape industrial power before they become mainstream narratives.

TSO / High confidence

Ubitium Says Its CGRA Can Boot Linux Without a Host CPU, Highlights RISC-V Compatibility

Ubitium GmbH announced on April 28, 2026, that its processor successfully booted and ran off-the-shelf Linux, describing it as the first CGRA capable of executing Linux without a host CPU. All three sources confirm this technical milestone; one source adds that the demo was based on an FPGA prototype and that the chip is compatible with the RISC-V toolchain. The sources do not mention specific performance, mass-production timing, or external validation.

Read analysis
TSO / High confidence

US, UK, Australia, Canada and New Zealand cyber agencies jointly issue guidance on secure agentic AI deployment

The U.S. CISA and NSA, together with cyber agencies in Australia, Canada, New Zealand and the United Kingdom, jointly released deployment guidance for agentic AI/AI agents on May 1, 2026. The core message is that these systems, which can autonomously carry out multi-step tasks, introduce greater cybersecurity risk and should be managed within existing security frameworks, using controls such as zero trust, least privilege and human approval. The three sources consistently confirm the joint release and risk-warning nature of the guidance, though the available source material does not provide a fully consistent set of technical details.

Read analysis
TSO / High confidence

Commonwealth Fusion Systems Enters PJM Interconnection Queue for the First Time, Aiming to Connect a 400MW Fusion Power Plant to the U.S. Grid

Commonwealth Fusion Systems has submitted an interconnection request to PJM Interconnection with the goal of connecting its planned first commercial fusion power plant to the U.S. grid. Three sources consistently confirm that the project is located in Virginia, has a planned capacity of 400MW, and is targeting power delivery in the early 2030s. However, differences remain across the sources regarding the project’s name, the timing of the application, and the details of its commercialization progress.

Read analysis
TSO / High confidence

Alamos Gold Q1 Results Meet Expectations: Net Income of $191.4 Million, Adjusted EPS of $0.54

Alamos Gold on Wednesday reported its first-quarter 2026 earnings, with three sources confirming net income of $191.4 million, earnings per share of $0.45, adjusted earnings per share of $0.54, and revenue of $596.7 million, all in line with Wall Street expectations. The sources did not note any additional discrepancies, and related details are based on the content jointly confirmed across the three sources.

Read analysis
TSO / High confidence

Intellia’s in vivo CRISPR therapy lonvo-z meets Phase 3 HAELO endpoints, rolling BLA filing begins

Intellia Therapeutics disclosed on April 27, 2026, that its in vivo CRISPR gene-editing therapy lonvo-z, formerly NTLA-2002, met the primary endpoint and all key secondary endpoints in the Phase 3 HAELO trial for hereditary angioedema (HAE), and has begun a rolling BLA submission to the U.S. FDA. Three sources consistently point to positive Phase 3 results and view the program as a milestone for the in vivo CRISPR field, with only minor differences in trial details and emphasis.

Read analysis
TSO / High confidence

Japan Airlines to trial humanoid robots in ground-handling operations at Haneda Airport from May 2026

Japan Airlines (JAL) will begin a humanoid robot trial at Tokyo’s Haneda Airport from May 2026 for ground-handling work. All three sources confirm this is a trial or demonstration project involving JAL and GMO AI & Robotics-related entities, aimed at easing pressure on ground staff. However, the exact task scope, wording of the partners, and project duration differ across the sources; some details mentioned in the Chinese report, such as “GMO Internet Group” and “China-made Unitree robots,” can only be partially verified from the provided sources and cannot be fully cross-checked.

Read analysis